Epstein Secrets

Herald (11/14, Wieder, Hall, 1.09M) reports, "A Justice Department look-back report into its abortive 2008 prosecution of Jeffrey Epstein found that the Federal Bureau of Investigation had planned to arrest Jeffrey Epstein in May 2007, but pulled back after the U.S. Attorney's Office for the Southern District of Florida, led by for

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

Herald (11/14, Wieder, Hall, 1.09M) reports, "A Justice Department look-back report into its abortive 2008 prosecution of Jeffrey Epstein found that the Federal Bureau of Investigation had planned to arrest Jeffrey Epstein in May 2007, but pulled back after the U.S. Attorney's Office for the Southern District of Florida, led by for

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

Herald (11/14, Wieder, Hall, 1.09M) reports, "A Justice Department look-back report into its abortive 2008 prosecution of Jeffrey Epstein found that the Federal Bureau of Investigation had planned to arrest Jeffrey Epstein in May 2007, but pulled back after the U.S. Attorney's Office for the Southern District of Florida, led by for

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying